Performance of BASDAI vs. ASDAS in Evaluating Axial Involvement in Patients with PsA Treated with Guselkumab: Pooled Analysis of Two Phase 3 Studies - ACR Meeting Abstracts

Por um escritor misterioso
Last updated 26 abril 2025
Performance of BASDAI vs. ASDAS in Evaluating Axial Involvement in Patients  with PsA Treated with Guselkumab: Pooled Analysis of Two Phase 3 Studies -  ACR Meeting Abstracts
Background/Purpose: Although the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) is used to assess the activity of axial disease in patients (pts) with PsA, only one of its questions is specific to axial symptoms. Alternatively, the Ankylosing Spondylitis Disease Activity Score (ASDAS) excludes assessment of enthesitis, gives less weight to peripheral activity and is considered […]
Performance of BASDAI vs. ASDAS in Evaluating Axial Involvement in Patients  with PsA Treated with Guselkumab: Pooled Analysis of Two Phase 3 Studies -  ACR Meeting Abstracts
PDF) Efficacy and safety of ixekizumab through 52 weeks in two phase 3, randomised, controlled clinical trials in patients with active radiographic axial spondyloarthritis (COAST-V and COAST-W)
Performance of BASDAI vs. ASDAS in Evaluating Axial Involvement in Patients  with PsA Treated with Guselkumab: Pooled Analysis of Two Phase 3 Studies -  ACR Meeting Abstracts
Oral Abstracts - 2020 - International Journal of Rheumatic Diseases - Wiley Online Library
Performance of BASDAI vs. ASDAS in Evaluating Axial Involvement in Patients  with PsA Treated with Guselkumab: Pooled Analysis of Two Phase 3 Studies -  ACR Meeting Abstracts
Efficacy and Safety of Upadacitinib in Patients with Psoriatic Arthritis and Axial Involvement - ACR Meeting Abstracts
Performance of BASDAI vs. ASDAS in Evaluating Axial Involvement in Patients  with PsA Treated with Guselkumab: Pooled Analysis of Two Phase 3 Studies -  ACR Meeting Abstracts
Treating to Target(s) With Interleukin-17 Inhibitors - Charles W. Lynde, Jennifer Beecker, Jan Dutz, Cathy Flanagan, Lyn C. Guenther, Wayne Gulliver, Kim Papp, Proton Rahman, Dalton Sholter, Gordon E. Searles, 2019
Performance of BASDAI vs. ASDAS in Evaluating Axial Involvement in Patients  with PsA Treated with Guselkumab: Pooled Analysis of Two Phase 3 Studies -  ACR Meeting Abstracts
Poster Abstract Presentation Abstracts - 2023 - International Journal of Rheumatic Diseases - Wiley Online Library
Performance of BASDAI vs. ASDAS in Evaluating Axial Involvement in Patients  with PsA Treated with Guselkumab: Pooled Analysis of Two Phase 3 Studies -  ACR Meeting Abstracts
PDF) Comparison of patients with axial PsA and patients with axSpA and concomitant psoriasis: an analysis of the German register RABBIT-SpA
Performance of BASDAI vs. ASDAS in Evaluating Axial Involvement in Patients  with PsA Treated with Guselkumab: Pooled Analysis of Two Phase 3 Studies -  ACR Meeting Abstracts
AB0894 Efficacy and Safety of Guselkumab in Biologic-Naïve Patients With Active Axial Psoriatic Arthritis: Study Design of a Phase 4, Randomized, Double-Blind, Placebo-Controlled Trial
Performance of BASDAI vs. ASDAS in Evaluating Axial Involvement in Patients  with PsA Treated with Guselkumab: Pooled Analysis of Two Phase 3 Studies -  ACR Meeting Abstracts
Guselkumab (TREMFYA®) Provides Consistent and Durable Pain Improvement in Patients with Active Psoriatic Arthritis: Results of 2 Phase 3, Randomized, Controlled Clinical Trials - ACR Meeting Abstracts
Performance of BASDAI vs. ASDAS in Evaluating Axial Involvement in Patients  with PsA Treated with Guselkumab: Pooled Analysis of Two Phase 3 Studies -  ACR Meeting Abstracts
Identification of PsA Phenotypes with Machine Learning Analytics Using Data from a Phase 3 Clinical Trial Program of Guselkumab in a Bio-naïve Population of Patients with PsA - ACR Meeting Abstracts
Performance of BASDAI vs. ASDAS in Evaluating Axial Involvement in Patients  with PsA Treated with Guselkumab: Pooled Analysis of Two Phase 3 Studies -  ACR Meeting Abstracts
New evidence on the management of spondyloarthritis
Performance of BASDAI vs. ASDAS in Evaluating Axial Involvement in Patients  with PsA Treated with Guselkumab: Pooled Analysis of Two Phase 3 Studies -  ACR Meeting Abstracts
Axial involvement in psoriatic arthritis: An update for rheumatologists - ScienceDirect
Performance of BASDAI vs. ASDAS in Evaluating Axial Involvement in Patients  with PsA Treated with Guselkumab: Pooled Analysis of Two Phase 3 Studies -  ACR Meeting Abstracts
Plenary Presentations - 2021 - International Journal of Rheumatic Diseases - Wiley Online Library
Performance of BASDAI vs. ASDAS in Evaluating Axial Involvement in Patients  with PsA Treated with Guselkumab: Pooled Analysis of Two Phase 3 Studies -  ACR Meeting Abstracts
Plenary Presentations - 2021 - International Journal of Rheumatic Diseases - Wiley Online Library

© 2014-2025 videoanalitik.net. All rights reserved.